3Iannccilli JD,Cronan JJ,Monchik JM.Risk for malignancy of thyroid nodules as assessed by sonographic criteria:the need for biopsy[J].J Ultrasound Med,2004,23:1455-1464. 被引量：1
4Hoang JK,Lee WK,Lee M,et al.US feature of thyoid malignancy:pearls and pitfalls[J].Radiographics,2007,27(12):847-860. 被引量：1
5Calliada F,Pallavicini D,et al.Topical role and future perspectives of sonographic contrast agents in the differential diagnosis of solid thyroid lesions[J].Rays,2010,25(10):191-197. 被引量：1
6Khoo ML,Asa SL,Witterick U,et al.Thyroid calcification and its association with thyroid carcinoma[J].Head Neck,2002,24(12):651-655. 被引量：1
7Sosa JA,Udelsman R.Papillary thyroid cancer[J].Surg Oncol Clin North Am,2006,15:585-601. 被引量：1
8Mazzaferri EL.Management of low-risk differentiated thyroid cancer[J].Endocr Pract,2007,13:498-512. 被引量：1
9Hughes DT,Haymart MR,Miller BS,et al.The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years[J].Thyroid,2011,21:231-236. 被引量：1
10Chen AY,Jemal A,Ward EM.Increasing incidence of differentiated thyroid cancer in the United States,1988-2005[J].Cancer,2009,115:3801-3807. 被引量：1
